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a B S T r a c T
One of the novel and progressive technology employed in pharmaceutical manufacturing, design of medical device and tissue engineering is 
three-dimensional (3d) printing. 3d printing technologies provide great advantages in 3d scaffolds fabrication over traditional methods in the 
control of pore size, porosity, and interconnectivity. Various techniques of 3d-printing include powder bed fusion, fused deposition modeling, 
binder deposition, inkjet printing, photopolymerization and many others which are still evolving. 3d-printing technique been employed in devel-
oping immediate release products, various systems to deliver multiple release modalities etc. 3d printing has opened the door for new generation 
of customized drug delivery with built-in flexibility for safer and effective therapy. Our mini-review provides a quick snapshot on an overview 
of 3d printing, various techniques employed, applications and its advancements in pharmaceutical sciences.
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currently, one of the novel and progressive technology employed in pharmaceutical manufacturing, design 
of medical device and tissue engineering is three-dimen-
sional (3d) printing. it follows the principles of additive 
manufacturing wherein layer-by-layer production is done 
in two dimensional (2d)-fashion to develop a 3d struc-
ture based on digital design. developing a pharmaceutical 
product by 3d-printing involves few basic common steps 
like: 1) developing a design of the final product; 2) con-
verting this design into a machine-readable format; 3) pro-
cessing the raw material; and 4) finally printing it followed 
by postprocessing steps if required.1 3d printing technolo-
gies provide great advantages in 3d scaffolds fabrication 
over traditional methods in the control of pore size, poros-
ity, and interconnectivity. The combination of 3d print-
ing technologies and drug delivery systems suggests the 
excellent possibilities in tissue formation.2
Approaches employed for 3D-printing
Various techniques of 3d-printing are available including 
powder bed fusion, fused deposition modeling, binder de-
position, inkjet printing, photopolymerization and many 
others which are still evolving. But, amongst all such 
techniques, very few are utilized in pharmaceutical pro-
duction. in 2015, powder bed fusion technique was used 
for processing of the first USFda approved 3d-printed 
fast-dissolving tablet (printlet), Spritam® (aprecia Phar-
maceuticals, Blue ash, OH, USa).3 This technique basi-
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powders, etc.8 With respect to development of 3d printed 
controlled release systems, certain multilayered bone im-
plants, formulations using porous paper substrates, etc 
were also developed using 3d printing technology.6
inkjet technique for 3d printing involves the spraying 
of molten mass which solidifies drop-by-drop to develop 
final 3d-structure. in photopolymerization 3d printing 
technique (also known as stereolithography), liquid res-
ins are exposed to high energy light source which can in-
duce polymerization into the resin. in case of Pen-based 
3d-printing, it utilizes extrusion principle where the ex-
trude layer-by-layer develops a final 3d product. Newer 
advanced techniques are also evolved such as racetrack 
printing, contour crafting, etc. They are providing vari-
ous advantages such as printing relatively flat products in 
less time, self-supportive products and a product with a 
smoother surface.
Applications of 3D-printing technique
With increasing advancements in technologies, product 
profile has also improved. initially, the 3d-printing tech-
nique was used to develop immediate release products, but 
the porous structure which is developed by this technique 
that retards the release of the drug provided scientist with 
a path to work on modified release products. also, re-
searchers are currently working on incorporating gradient 
of excipients to control the release; utilization of osmotic 
delivery system in 3d printed products to deliver multiple 
release modalities; modulating system in such a way as 
to achieve structured break down of the solid oral dosage 
form in order to deposit different parts in different regions 
of lumen, etc.
3d-printing of pharmaceutical products provides ad-
vantages of developing complex products with accuracy 
because it has completed digital control over the printing 
process. it also provides the major benefit of personaliza-
tion of medicaments, wherein the amount of drug can be 
tailored as per the requirement, making it more patient 
compliant and finally improving the treatment regimen. 
additionally, 3d-printing technology is cheap and less 
time to consume as compared to the conventional tech-
niques which provide an advantage of on-demand manu-
facturing in some medical emergency situations.1, 9
3d-printing has been utilized for preparation of vari-
ous pharmaceutical products such as fast-disintegrating 
tablets, multi-layered caplets, microneedles, implants and 
many others. currently, scientists are even working on 
merging two vast technologies, nanotechnology and 3d-
low melting point binders. But, despite the successful 
launch of the first product, there were certain drawbacks 
associated with powder bed fusion technique such as poor 
mechanical properties and surface imperfections. con-
sidering such drawbacks, researchers started working on 
semi-solid extrusion 3d-printing technique, wherein the 
semi-solid form of raw materials is passed through syringe 
head to develop bilayered tablets, polypills, etc. due to the 
associated disadvantages like requirement of postopera-
tive drying, high friability tablets etc., this technology also 
doesn’t sustain longer.4
Fused filament fabrication (FFF) method of 3d-printing 
overcomes the limitations associated with earlier men-
tioned technologies and provided certain advantages such 
as ready-to-use product with high mechanical strength 
and high resolution. This process is widely known with 
its trademark name called Fused deposition modeling 
(Fdm). The Fdm technique involves utilization of hot 
melt extrusion (Hme) technique to develop thermoplas-
tic filaments (mainly of polymer), which are then fed into 
the 3d printer to develop a 3d product with layer-by-layer 
deposition technique. Hme makes it easy to load the drug 
onto the filament, which instead includes impregnating 
drug on the commercially available filaments which is a 
slow and cumbersome process.4, 5 Zhang et. al. prepared 
aceclofenac loaded tablets using Fdm technology in com-
bination with Hme technology and studied the impact of 
different grades of polymers in different ratio on the re-
lease rate of drug.6
despite its wide-scale applications, FFF also encom-
passes drawbacks, one of which is a narrow range of 
polymers which can be used as carriers for drugs in 3d-
printing. additionally, these pharmaceutical grade poly-
mers lack mechanical properties, flexibility, and thermal 
stability which are essential components in processing by 
3d-printing technology. apart from this, another impor-
tant drawback includes improper miscibility of the drug 
in the polymer, which is due to semi-crystalline nature of 
the polymer used. To overcome some of these limitations, 
nowadays some immiscible fillers and plasticizers (eu-
dragit®, PeG-400, evonik Health care, essen, Germany) 
are incorporated into the 3d-printed products. However, 
the ratio of polymer to filler used needs to be optimized to 
obtain a quality 3d-print.7
meanwhile, many different techniques were developed 
in order to fabricate 3d printed macro and micro scale sys-
tems, which could improve drug loading, give controlled 
release and many other advantages. and this was only pos-














PROFF ID.indd   1 10/09/10   14:28
3d-PriNTiNG SiNGHVi
Vol. 60 - No. ?? PaNmiNerVa medica 3
including banding, residuals, warping, leaning, etc. To 
overcome these issues associated with the 3d-printing 
technology of pharmaceuticals, there is need to improve 
existing processing equipment of 3d-printing.1 The fusion 
of advanced drug delivery using 3d printing technology 
with conventional pharmaceutical technologies can be 
anticipated to utilize the advantages of 3d printing with 
proven effectiveness of conventional technologies for the 
development of customized, precise and cost-effective 
drug delivery systems.
But, as 3d-printed pharmaceuticals are patentable in 
nature, their regulatory control also plays an important 
role. The Fda is currently approving 3d printed medical 
devices through the 510(k) regulatory process. in 2016, a 
draft guidance has been issued by USFda on the Technical 
considerations for additive manufactured devices for the 
manufacturer of 3d printing-based devices. However, it is 
still questionable whether Fda will consider just the 3d-
printed product or the 3d-printer or both of them. Thus, 
the approval of first 3d-printed pharmaceutical product 
does not assure that next upcoming products will also be 
approved.13, 14 For effective product evaluation and ap-
proval, regulatory agencies are working on to understand 
the effect of 3d geometric design, material attributes, and 
3d printing process parameters on the performance of 3d-
printed solid dosage forms. regulatory bodies also felt 
the need of mechanistic models for 3d printing processes 
which can be utilized as predictive tool for product per-
formance in different disease and patient conditions. it is 
expected that current research on 3d printing with regu-
latory requirement can bring the most effective and safer 
pharmaceutical product.14
Conclusions
3d printing has opened the door for new generation of cus-
tomized drug delivery with built-in flexibility for safer and 
effective therapy. This new tool is gaining enormous atten-
tion which is not only restricted to pharmaceuticals in de-
signing customized drug delivery systems but also expand-
ing its horizons in the area of tissue engineering etc. Over-
all, this technology is bringing advancements and revolu-
tion in the area of pharmaceutical and biological sciences.
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